Eastern Health has services across the largest geographical area
We deliver more than 1.4 million episodes of patient care annually
- 35,667 Surgeries
- 1.43 million episodes of care
- 290,413 Specialty clinic appointments
- 145,248 Emergency department presentations
Eastern Health: Advancing Research and Clinical Trials
At Eastern Health, our rich history is connected with our commitment to serving our diverse community and undertake innovative collaborative research.
We have strategic partnerships that span foundations, research institutes, universities, health services, and government bodies. These collaborations allow us to drive innovation, enhance patient care, and advance medical knowledge.
Our Resources
At Eastern Health, we have the capacity to undertake trials from Phase Ib to Phase IV. We have a long record of accomplishment of conducting clinical trials in many health specialties, including:
Addiction
Allied Health
Breast oncology
Cardiology
Endocrinology & diabetes
Gastroenterology & hepatology
Geriatric medicine
Haematology
Intensive care medicine
Mental Health
Nephrology (Renal)
Neurology
Oncology
Palliative care
Pharmacy
Quality and Patient Safety
Rehabilitation medicine
Respiratory & sleep medicine
Rheumatology
Surgery
More information about these research programs can be found here
As a large hospital network, Eastern Health offers effective management and coordination of clinical trials through the support of a range of services.
We offer many services and specialist clinics for patients across the Eastern Health network.
This includes:
Clinical Trials Pharmacy
Diagnostic Imaging
Pathology Services
Eastern Clinical Research Unit (ECRU) is part of the Monash University Eastern Health Clinical School.
The Eastern Clinical Research Unit (ECRU) provides clinical trial coordination services for some of Eastern Health’s clinical trials. ECRU is able to support smaller speciality units, which gives more treatment options for our patients to consider.
ECRU provides expert service in clinical trials for health organisations and the biotechnology sector, as well as support for independent principal investigator-driven studies. ECRU is involved in more than 150 active clinical trials, with more than 1,500 patients. A large team of over 40 clinical trial coordinators work with a variety of disciplinary groups.
Our clinical trial staff have experience in lead site ethics application coordination and submission to a reviewing HREC.
Our organisation has a robust but timely governance process. More information regarding ethics and governance requirements can be found here.
Here at Eastern Health, we understand the importance of careful assessment of feasibility of trial sites for clinical trials.
Please contact the relevant specialty to arrange a site feasibility assessment.
More information about these research programs can be found here
At Eastern Health the Investigator who has been approached by the Sponsor to run the trial does not have the authority to sign these agreements. Only Director of Research or their delegate has the legal authority to ratify the confidentiality and non-disclosure agreements on behalf of Eastern Health.
Eastern Health can enter into either a Master/Institutional or study specific confidentiality agreements. To reduce delays in signing of CDAs please note the following guidance.
Name and Address:
The legal name and address for Eastern Health are as follows:
Eastern Health
Level 4, 5 Arnold Street, Box Hill, Victoria, 3128, Australia
Governing Jurisdiction:
Eastern Health cannot accept USA and Canada as governing jurisdictions. We prefer that Victoria, Australia is the nominated jurisdiction.
Confidential Material
Include a clause that one copy of confidential information for the purposes of the feasibility assessment will be kept by the institution.
All communication with the Eastern Health regarding CDAs should preferably be via the investigator although the Office of research and Ethics can facilitate initial contact. The appropriate principal investigator will lead the determination if undertaking the proposed clinical trial at Eastern Health is feasible.